We investigated this issue by conducting a systematic review and meta-analysis of studies reporting circulating paraoxonase-1 concentrations in patients with schizophrenia and healthy controls and assessing possible associations between the effect size of paraoxonase and arylesterase activity and pre-defined variables. This evidence concerns the gene PON1 and schizophrenia.